We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+7.77%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$5B
AUM Growth
+$283M
Cap. Flow
-$6.9M
Cap. Flow %
-0.14%
Top 10 Hldgs %
18.22%
Holding
1,507
New
129
Increased
613
Reduced
585
Closed
96

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$9.57M
2
AAPL icon
Apple
AAPL
+$7.32M
3
ABB
ABB Ltd
ABB
+$7.11M
4
NVDA icon
NVIDIA
NVDA
+$6.77M
5
ALL icon
Allstate
ALL
+$6.29M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Financials 10.19%
3 Healthcare 9.77%
4 Industrials 9.03%
5 Consumer Discretionary 7.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZTS icon
101
Zoetis
ZTS
$32.4B
$10.6M 0.21%
61,511
-13
-0% -$2.25K
XLK icon
102
State Street Technology Select Sector SPDR ETF
XLK
$115B
$10.6M 0.21%
121,508
+25,696
+27% +$2.03M
NFLX icon
103
Netflix
NFLX
$299B
$10.4M 0.21%
235,780
-7,560
-3% -$278K
NOBL icon
104
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.7B
$10.2M 0.21%
217,380
-2,928
-1% -$134K
BLK icon
105
Blackrock
BLK
$169B
$10.2M 0.2%
14,783
+1,162
+9% +$778K
VO icon
106
Vanguard Morningstar Mid-Cap ETF
VO
$106B
$10.2M 0.2%
185,184
+13,320
+8% +$698K
MO icon
107
Altria Group
MO
$114B
$10.2M 0.2%
224,969
+295
+0.1% +$13.4K
KO icon
108
Coca-Cola
KO
$377B
$10.2M 0.2%
169,019
-10,432
-6% -$649K
TXN icon
109
Texas Instruments
TXN
$252B
$10.1M 0.2%
56,183
-1,399
-2% -$241K
CARR icon
110
Carrier Global
CARR
$51B
$10.1M 0.2%
202,609
-3,285
-2% -$145K
CP icon
111
Canadian Pacific Kansas City
CP
$78.1B
$9.84M 0.2%
121,843
+11,280
+10% +$891K
NVO
112
Novo Nordisk
NVO
$208B
$9.69M 0.19%
119,734
+5,692
+5% +$465K
SCHW
113
Charles Schwab
SCHW
$183B
$9.34M 0.19%
164,843
+3,738
+2% +$196K
AMT icon
114
American Tower
AMT
$80.8B
$9.32M 0.19%
48,064
-1,645
-3% -$322K
XLE icon
115
State Street Energy Select Sector SPDR ETF
XLE
$39.6B
$9.28M 0.19%
228,710
-57,936
-20% -$2.36M
EMR icon
116
Emerson Electric
EMR
$83.9B
$9.28M 0.19%
102,615
+3,472
+4% +$292K
INTC icon
117
Intel
INTC
$455B
$9.23M 0.18%
275,880
+10,143
+4% +$318K
COWZ icon
118
Pacer US Cash Cows 100 ETF
COWZ
$18.8B
$9.11M 0.18%
190,308
+45,030
+31% +$2.09M
WY icon
119
Weyerhaeuser
WY
$18B
$9.06M 0.18%
270,387
-22,077
-8% -$665K
VCSH icon
120
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$9.03M 0.18%
119,387
+6,900
+6% +$524K
ETRN
121
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
$8.95M 0.18%
936,310
+528,330
+129% +$3.55M
TJX icon
122
TJX Companies
TJX
$174B
$8.9M 0.18%
105,016
+17,188
+20% +$1.36M
VWO icon
123
Vanguard FTSE Emerging Markets ETF
VWO
$121B
$8.84M 0.18%
217,231
-1,191
-0.5% -$48K
UPS icon
124
United Parcel Service
UPS
$88.6B
$8.8M 0.18%
49,083
+4,610
+10% +$819K
ADI icon
125
Analog Devices
ADI
$179B
$8.75M 0.18%
44,904
-5,069
-10% -$939K

Similar funds

Oppenheimer & Co's Q2 2023 Portfolio in Review

As of Q2 2023, Oppenheimer & Co held 1,507 positions worth $5B, up 6% from $4.72B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Oppenheimer & Co's Q2 2023 filing shows 129 new, 613 increased, 585 reduced and 96 closed positions. Its largest new stake was Ovintiv: 88,415 shares worth $3.37M. The largest sale was Microsoft, an estimated $9.57M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Oppenheimer & Co's largest Q2 2023 buy was Ovintiv: 88,415 shares worth $3.37M.
  • Oppenheimer & Co added most to BlackBerry in Q2 2023, an estimated $5.12M increase.
  • Oppenheimer & Co's biggest Q2 2023 reduction was Microsoft, cutting an estimated $9.57M.
  • Oppenheimer & Co fully exited ABB Ltd in Q2 2023, selling an estimated $7.11M.
  • Oppenheimer & Co's ten largest holdings make up 18% of its $5B portfolio in Q2 2023.
  • Oppenheimer & Co opened 129 new positions and closed 96 in Q2 2023.
  • Oppenheimer & Co's portfolio value rose 6% quarter-over-quarter to $5B.

Based on Oppenheimer & Co's 13F filing for Q2 2023, filed 3 Aug 2023.